ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Performing multiple biomarker tests delays initiation of amyloid-targeting treatments.

Anna Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.